Outcome variable | Perceval (n = 42) | Magna (n = 28) | p-Value |
Platelet transfusion | 10 (24%) | 10 (36%) | N/S |
Fresh frozen plasma transfusion | 12 (29%) | 12 (43%) | N/S |
Cryoprecipitate transfusion | 3 (7%) | 1 (4%) | N/S |
In-hospital mortality | 1 (2%) | 0 | N/S |
Re-explored for bleeding/tamponade | 3 (7%) | 1 (4%) | N/S |
Length of ICU stay (days) Mean ± SD |
4.1 ± 1.9 |
6.9 ± 13.8 |
0.001* |
Length of hospital stay (days) Mean ± SD |
13.7 ± 7.0 |
17.7 ± 14.5 |
0.001* |
Neurological complication | 0 | 1 (4%) | N/S |
Atrial fibrillation | 4 (10%) | 2 (7%) | N/S |
Renal complication | 2 (5%) | 1 (4%) | N/S |
Permanent pacemaker | 2 (5%) | 3 (11%) | N/S |
Low cardiac output state | 0 | 2 (7%) | N/S |
Respiratory complications | 4 (10%) | 2 (7%) | N/S |
Sternal Wound infection | 1 (2%) | 0 | N/S |